Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DNA sequencing
MedTech
Illumina previews updated tumor research assay, ships IVD kits
Version 2 of the TruSight Oncology 500 research-use-only assay is currently under development, the company said, with its release set for mid-2025.
Conor Hale
Nov 22, 2024 9:30am
Illumina updates benchtop sequencer with push-button workflows
Oct 9, 2024 12:10pm
Illumina buys Fluent BioSciences for single-cell analysis tech
Jul 10, 2024 10:30am
Roche sues Stanford, Foresight Diagnostics over trade secrets
Jul 3, 2024 10:44am
Beyond A, B, O: Thermo Fisher unveils test for rare blood types
May 16, 2024 12:30pm
Bruker brokers $392M deal for frayed NanoString
Apr 18, 2024 11:24am